BNP survival regression with variable dimension covariate vector
|
|
- Benjamin Russell
- 5 years ago
- Views:
Transcription
1 BNP survival regression with variable dimension covariate vector Peter Müller, UT Austin Survival Truth Estimate Survival Truth Estimate BC, BRAF TT (left), S (right) Time Time
2 BNP survival regression with variable dimension covariate vector Peter Müller, UT Austin Survival Truth Estimate Survival Truth Estimate BC, BRAF TT (left), S (right) Time Time TRT TUMOR PFS CENS MUTATIONS m1 m2 m3 m4 m5 m6 m7 m8... TT THYROID NA NA NA NA NA NA NA NA TT THYROID NA NA 0 NA NA S OVARIAN NA S MELANOMA NA NA
3 A study for targeted therapy slide 2 of Clinical Trial of Targeted Therapies w. Don Berry & Lia Tsimbouridou, M.D. Anderson, Riten Mitra, U. Louisville, Yanxun Xu, JHU, Clinical trial: study of targeted therapy (TT) vs. standard care (S) in metastatic cancers. patients with metastatic cancers (thyroid, ovarian, melano, lung, breast, CRC and other) Objective: determine whether TT leads to > progression free survival (PFS)
4 study for targeted therapy slide 2 of Clinical Trial of Targeted Therapies w. Don Berry & Lia Tsimbouridou, M.D. Anderson, Riten Mitra, U. Louisville, Yanxun Xu, JHU, Clinical trial: study of targeted therapy (TT) vs. standard care (S) in metastatic cancers. patients with metastatic cancers (thyroid, ovarian, melano, lung, breast, CRC and other) Objective: determine whether TT leads to > progression free survival (PFS) Secondary objective: find subgroups for reporting of winning subgroup for future study
5 study for targeted therapy slide 2 of Clinical Trial of Targeted Therapies w. Don Berry & Lia Tsimbouridou, M.D. Anderson, Riten Mitra, U. Louisville, Yanxun Xu, JHU, Clinical trial: study of targeted therapy (TT) vs. standard care (S) in metastatic cancers. patients with metastatic cancers (thyroid, ovarian, melano, lung, breast, CRC and other) Objective: determine whether TT leads to > progression free survival (PFS) Secondary objective: find subgroups for reporting of winning subgroup for future study adaptive treatment allocation
6 study for targeted therapy slide 2 of Clinical Trial of Targeted Therapies w. Don Berry & Lia Tsimbouridou, M.D. Anderson, Riten Mitra, U. Louisville, Yanxun Xu, JHU, Clinical trial: study of targeted therapy (TT) vs. standard care (S) in metastatic cancers. patients with metastatic cancers (thyroid, ovarian, melano, lung, breast, CRC and other) Objective: determine whether TT leads to > progression free survival (PFS) Secondary objective: find subgroups for reporting of winning subgroup for future study adaptive treatment allocation heterogeneous pat population different mutations; different cancers; basline covs... Treatment might be effective in a sub-population
7 Model slide 3 of BNP survival regression for variable dim x with F. Quintana, PUCC, Chile and Gary Rosner, JHU. Variables: for each patient i = 1,..., n Outcome y i PFS; Covariates x i = (c i, m i, b i ) tumor type ci {1,..., C} (categorical) molecular aberrations mi = (m i1,..., m im ) with m is = 1 for observed aberration, m is = 1 for not observed (and 0 for n/a). other baseline covariates bi (age, # prior threrapies, etc.)
8 Model slide 3 of BNP survival regression for variable dim x with F. Quintana, PUCC, Chile and Gary Rosner, JHU. Variables: for each patient i = 1,..., n Outcome y i PFS; Covariates x i = (c i, m i, b i ) tumor type ci {1,..., C} (categorical) molecular aberrations mi = (m i1,..., m im ) with m is = 1 for observed aberration, m is = 1 for not observed (and 0 for n/a). other baseline covariates bi (age, # prior threrapies, etc.) Challenges: prob model needs to allow for many m j are not recorded var dimension covariate vector x i = (m i, c i, b i ),
9 Model slide 3 of BNP survival regression for variable dim x with F. Quintana, PUCC, Chile and Gary Rosner, JHU. Variables: for each patient i = 1,..., n Outcome y i PFS; Covariates x i = (c i, m i, b i ) tumor type ci {1,..., C} (categorical) molecular aberrations mi = (m i1,..., m im ) with m is = 1 for observed aberration, m is = 1 for not observed (and 0 for n/a). other baseline covariates bi (age, # prior threrapies, etc.) Challenges: prob model needs to allow for many m j are not recorded var dimension covariate vector x i = (m i, c i, b i ), extrapolation with small # obs.
10 Model slide 3 of BNP survival regression for variable dim x with F. Quintana, PUCC, Chile and Gary Rosner, JHU. Variables: for each patient i = 1,..., n Outcome y i PFS; Covariates x i = (c i, m i, b i ) tumor type ci {1,..., C} (categorical) molecular aberrations mi = (m i1,..., m im ) with m is = 1 for observed aberration, m is = 1 for not observed (and 0 for n/a). other baseline covariates bi (age, # prior threrapies, etc.) Challenges: prob model needs to allow for many m j are not recorded var dimension covariate vector x i = (m i, c i, b i ), extrapolation with small # obs. interacations of m j
11 Random Partition s = (s 1,..., s n ) = cluster membership indicators s i {1,..., J}. Let y j and x j variables by cluster and S j = {i : s i = j}.
12 Random Partition s = (s 1,..., s n ) = cluster membership indicators s i {1,..., J}. Let y j and x j variables by cluster and S j = {i : s i = j}. Random partition: p(s x), favor clusters homogeneous in x i.
13 Random Partition s = (s 1,..., s n ) = cluster membership indicators s i {1,..., J}. Let y j and x j variables by cluster and S j = {i : s i = j}. Random partition: p(s x), favor clusters homogeneous in x i. Sampling model: exchangeable within clusters p(y s, x, ξ) = J j=1 i S j p(y i ξ j )
14 Random Partition s = (s 1,..., s n ) = cluster membership indicators s i {1,..., J}. Let y j and x j variables by cluster and S j = {i : s i = j}. Random partition: p(s x), favor clusters homogeneous in x i. Sampling model: exchangeable within clusters p(y s, x, ξ) = J j=1 i S j p(y i ξ j ) Prediction: future patient i = n + 1 is matched with one of the earlier clusters, on the basis of similar covariates x i = (c i, m i, b i ). predict similar PFS. That s all!
15 Model slide 5 of 15 Covariate dependent partition Random partition: J p(s x) c(s j ) g(x j ) j=1 favor clusters homogeneous in x i ;
16 Model slide 5 of 15 Covariate dependent partition Random partition: p(s x) J c(s j ) g(x j ) j=1 favor clusters homogeneous in x i ; with g(x j ) scoring similarity of x j = (x i ; i S j ); special case of PPM (Hartigan, 1990; Barry & Hartigan 1993)
17 odel slide 5 of 15 Covariate dependent partition Random partition: p(s x) J c(s j ) g(x j ) j=1 favor clusters homogeneous in x i ; with g(x j ) scoring similarity of x j = (x i ; i S j ); special case of PPM (Hartigan, 1990; Barry & Hartigan 1993) Similarity function: over observed covariates only. Assume only 1 covariate: g(x j ) = g ({x i, i S j
18 odel slide 5 of 15 Covariate dependent partition Random partition: p(s x) J c(s j ) g(x j ) j=1 favor clusters homogeneous in x i ; with g(x j ) scoring similarity of x j = (x i ; i S j ); special case of PPM (Hartigan, 1990; Barry & Hartigan 1993) Similarity function: over observed covariates only. Assume only 1 covariate: g(x j ) = g ({x i, i S j and x i observed }) S j = S j {i : x i observed }
19 Model slide 6 of 15 Default construction single covariate x il : with auxiliary model q(x i ξ j ) and aux prior q(ξ j ) i S j g(x j ) = q(x i ξ j ) q(ξ j) dξ j i S j analytical evaluation with conjugate pairs q(x ξ), q(ξ) for continuous, binary, count etc. Easy extension to mv continous vector etc.
20 odel slide 6 of 15 Default construction single covariate x il : with auxiliary model q(x i ξ j ) and aux prior q(ξ j ) i S j g(x j ) = q(x i ξ j ) q(ξ j) dξ j i S j analytical evaluation with conjugate pairs q(x ξ), q(ξ) for continuous, binary, count etc. Easy extension to mv continous vector etc. Multiple covariates: for mix of multiple data types g(x j ) = L g l (x jl ) l=1 with product over covariates (covariate subvectors)
21 Computation Scaled g(x j ): scale with q(x il ξ l ) for any choice of ξ g l (x jl ) = g l (x jl ) i S j q(x il ξ l ),
22 Model slide 7 of 15 Computation Scaled g(x j ): scale with q(x il ξ l ) for any choice of ξ g l (x jl ) = g l (x jl ) i S j q(x il ξ l ), Evaluation: simplifies to g l (x j ) = q( ξ) q( ξ x jl ).
23 Model slide 7 of 15 Computation Scaled g(x j ): scale with q(x il ξ l ) for any choice of ξ g l (x jl ) = g l (x jl ) i S j q(x il ξ l ), Evaluation: simplifies to g l (x j ) = q( ξ) q( ξ x jl ). MCMC: use any posterior MCMC for DPM, with modified prior probs
24 Model slide 7 of 15 Computation Scaled g(x j ): scale with q(x il ξ l ) for any choice of ξ g l (x jl ) = g l (x jl ) i S j q(x il ξ l ), Evaluation: simplifies to g l (x j ) = q( ξ) q( ξ x jl ). MCMC: use any posterior MCMC for DPM, with modified prior probs Variable selection: could add variable selection with γ jl {0, 1} (Quintana, M & Papoila, ScanJ, 2015).
25 BNP survival regression results slide 8 of Results p(k data) k PATIENTS PATIENTS (a) p(k y) (b) co-clustering probs
26 BNP survival regression results slide 9 of 15 TRT BRCA TRT BRAF clusters by... TRT TP53 (a) %BRCA and %TT (b) %BRAF and %TT (b) %P53 & TT
27 Application to subgroup analysis slide 10 of Bayesian Subgroup analysis Treatment/cov interaction: Dixon and Simon (1991, Bmcs), Simon (2002, StatMed), Jones et al. (2011, ClinTrials) Tree based methods: Foster, Taylor & Ruberg (2011, StatMed) Model selection: Berger, Wang and Shen (2014, JBiophStat), Sivaganesan et al. (2011, StatMed) Decision problem: next slides...
28 pplication to subgroup analysis slide 11 of 15 Decision Problem Data: response y i (PFS), covariates x i = (x i1,..., x ip ).
29 pplication to subgroup analysis slide 11 of 15 Decision Problem Data: response y i (PFS), covariates x i = (x i1,..., x ip ). Actions: Report a (i.e., one) subgroup of patients who might most benefit from the experimental therapy: a = (I, x o ), Covariates: I {1,..., p} Levels: x o = (x o l, l I ). Population finding: recommend subpop {x il = x o l, l I }
30 pplication to subgroup analysis slide 11 of 15 Decision Problem Data: response y i (PFS), covariates x i = (x i1,..., x ip ). Actions: Report a (i.e., one) subgroup of patients who might most benefit from the experimental therapy: a = (I, x o ), Covariates: I {1,..., p} Levels: x o = (x o l, l I ). Population finding: recommend subpop {x il = x o l, l I } Decision problem: separate inference (predicting PFS)
31 pplication to subgroup analysis slide 11 of 15 Decision Problem Data: response y i (PFS), covariates x i = (x i1,..., x ip ). Actions: Report a (i.e., one) subgroup of patients who might most benefit from the experimental therapy: a = (I, x o ), Covariates: I {1,..., p} Levels: x o = (x o l, l I ). Population finding: recommend subpop {x il = x o l, l I } Decision problem: separate inference (predicting PFS) vs. decision (report subpopulation).
32 pplication to subgroup analysis slide 11 of 15 Decision Problem Data: response y i (PFS), covariates x i = (x i1,..., x ip ). Actions: Report a (i.e., one) subgroup of patients who might most benefit from the experimental therapy: a = (I, x o ), Covariates: I {1,..., p} Levels: x o = (x o l, l I ). Population finding: recommend subpop {x il = x o l, l I } Decision problem: separate inference (predicting PFS) vs. decision (report subpopulation). no need for multiplicity control arbitrary prob model, e.g. BNP survival regression
33 Utility: we favor a subpopulation with difference (relative to the overall population) in log hazards ratio (LR), large size and parsimonious description with few covariates pplication to subgroup analysis slide 12 of 15
34 pplication to subgroup analysis slide 12 of 15 Utility: we favor a subpopulation with difference (relative to the overall population) in log hazards ratio (LR), large size and parsimonious description with few covariates u(a, θ) = (LR(a, θ) β) n(a) α ( I + 1) γ with β > 0 a fixed clinically decided threshold and n(a) is the size of the subpopulation. θ indexes the sampling model
35 pplication to subgroup analysis slide 12 of 15 Utility: we favor a subpopulation with difference (relative to the overall population) in log hazards ratio (LR), large size and parsimonious description with few covariates u(a, θ) = (LR(a, θ) β) n(a) α ( I + 1) γ with β > 0 a fixed clinically decided threshold and n(a) is the size of the subpopulation. θ indexes the sampling model (any model for p(y x, θ))
36 pplication to subgroup analysis slide 12 of 15 Utility: we favor a subpopulation with difference (relative to the overall population) in log hazards ratio (LR), large size and parsimonious description with few covariates u(a, θ) = (LR(a, θ) β) n(a) α ( I + 1) γ with β > 0 a fixed clinically decided threshold and n(a) is the size of the subpopulation. θ indexes the sampling model (any model for p(y x, θ)) Bayes rule: Report a = arg max a u(a, θ) dp(θ data)
37 pplication to subgroup analysis slide 12 of 15 Utility: we favor a subpopulation with difference (relative to the overall population) in log hazards ratio (LR), large size and parsimonious description with few covariates u(a, θ) = (LR(a, θ) β) n(a) α ( I + 1) γ with β > 0 a fixed clinically decided threshold and n(a) is the size of the subpopulation. θ indexes the sampling model (any model for p(y x, θ)) Bayes rule: Report a = arg max a u(a, θ) dp(θ data) Model: Decicsion problem and solution meaningful for any model. We compute the expectations w.r.t. the BNP survival regression.
38 Application to subgroup analysis slide 13 of 15 Operating Characteristics: Error Rates TIE = p(h0 c H 0) type-i error FNR = p(h 0 H0 c ) false negative rate TPR = p(h 1 H 1 ) true positive r. FSR = p(h a Ha c ) false subgroup r. TSR = p(h a H a ) true subgroup r. FPR = p(h 1 H a ) false positive r.
39 Application to subgroup analysis slide 13 of 15 Operating Characteristics: Error Rates TIE = p(h0 c H 0) type-i error FNR = p(h 0 H0 c ) false negative rate TPR = p(h 1 H 1 ) true positive r. FSR = p(h a Ha c ) false subgroup r. TSR = p(h a H a ) true subgroup r. FPR = p(h 1 H a ) false positive r. p(a B) = frequentist probability of A over repeat simulation under truth B. Truth Subgroup Effect Decision H 0 H a H 1 H 0 1-TIE FNR H a TSR a FSR H 1 FPR a TPR
40 Application to subgroup analysis slide 13 of 15 Operating Characteristics: Error Rates TIE = p(h0 c H 0) type-i error FNR = p(h 0 H0 c ) false negative rate TPR = p(h 1 H 1 ) true positive r. FSR = p(h a Ha c ) false subgroup r. TSR = p(h a H a ) true subgroup r. FPR = p(h 1 H a ) false positive r. p(a B) = frequentist probability of A over repeat simulation under truth B. Truth Subgroup Effect Decision H 0 H a H 1 H 0 1-TIE FNR H a TSR a FSR H 1 FPR a TPR Choose c 0 to control TIE, and c 1 to control (average) FSR.
41 Application to subgroup analysis slide 13 of 15 Operating Characteristics: Error Rates TIE = p(h0 c H 0) type-i error FNR = p(h 0 H0 c ) false negative rate TPR = p(h 1 H 1 ) true positive r. FSR = p(h a Ha c ) false subgroup r. TSR = p(h a H a ) true subgroup r. FPR = p(h 1 H a ) false positive r. p(a B) = frequentist probability of A over repeat simulation under truth B. Truth Subgroup Effect Decision H 0 H a H 1 H 0 1-TIE FNR H a TSR a FSR H 1 FPR a TPR Choose c 0 to control TIE, and c 1 to control (average) FSR. All but the TIE require additional specification: effect size for FNR, TPR and FSR. TSR and FPR depend on specific subgroup a.
42 Application to subgroup analysis slide 14 of 15 Simulation results Scenario TIE TSR TPR FSR FNR FPR TIE = Pr(H c 0 H 0); TSR = Pr(a a); TPR = Pr(H 1 H 1 ); FSR = Pr(a a c ); FNR = Pr(H 0 H c 0 ); and FPR = Pr(H 1 H c 1 ).
43 Application to subgroup analysis slide 14 of 15 Simulation results Scenario TIE TSR TPR FSR FNR FPR TIE = Pr(H c 0 H 0); TSR = Pr(a a); TPR = Pr(H 1 H 1 ); FSR = Pr(a a c ); FNR = Pr(H 0 H c 0 ); and FPR = Pr(H 1 H c 1 ). scenario 2 is true H 0 others are true subgroup & overall effects
44 Application to subgroup analysis slide 15 of 15 Summary BNP survival regression, with arbitrary interactions (clusters), variable dim cov vectors, no extrapolation useful for prediction, not for interpretation of parameters Example: subgroup analysis; implements multiplicity control choice of priors, by controlling frequentist error rate. Extension: variable selection within each cluster
Individualized Treatment Effects with Censored Data via Nonparametric Accelerated Failure Time Models
Individualized Treatment Effects with Censored Data via Nonparametric Accelerated Failure Time Models Nicholas C. Henderson Thomas A. Louis Gary Rosner Ravi Varadhan Johns Hopkins University July 31, 2018
More informationMultivariate Survival Analysis
Multivariate Survival Analysis Previously we have assumed that either (X i, δ i ) or (X i, δ i, Z i ), i = 1,..., n, are i.i.d.. This may not always be the case. Multivariate survival data can arise in
More informationA Bayesian Nonparametric Approach to Monotone Missing Data in Longitudinal Studies with Informative Missingness
A Bayesian Nonparametric Approach to Monotone Missing Data in Longitudinal Studies with Informative Missingness A. Linero and M. Daniels UF, UT-Austin SRC 2014, Galveston, TX 1 Background 2 Working model
More informationMeta-Analysis for Diagnostic Test Data: a Bayesian Approach
Meta-Analysis for Diagnostic Test Data: a Bayesian Approach Pablo E. Verde Coordination Centre for Clinical Trials Heinrich Heine Universität Düsseldorf Preliminaries: motivations for systematic reviews
More informationTowards stratified medicine instead of dichotomization, estimate a treatment effect function for a continuous covariate
Towards stratified medicine instead of dichotomization, estimate a treatment effect function for a continuous covariate Willi Sauerbrei 1, Patrick Royston 2 1 IMBI, University Medical Center Freiburg 2
More informationModeling & Simulation to Improve the Design of Clinical Trials
Modeling & Simulation to Improve the Design of Clinical Trials Gary L. Rosner Oncology Biostatistics and Bioinformatics The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Joint work with Lorenzo
More informationMachine Learning Linear Classification. Prof. Matteo Matteucci
Machine Learning Linear Classification Prof. Matteo Matteucci Recall from the first lecture 2 X R p Regression Y R Continuous Output X R p Y {Ω 0, Ω 1,, Ω K } Classification Discrete Output X R p Y (X)
More informationInterim Monitoring of Clinical Trials: Decision Theory, Dynamic Programming. and Optimal Stopping
Interim Monitoring of Clinical Trials: Decision Theory, Dynamic Programming and Optimal Stopping Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj
More informationBayesian Nonparametric Accelerated Failure Time Models for Analyzing Heterogeneous Treatment Effects
Bayesian Nonparametric Accelerated Failure Time Models for Analyzing Heterogeneous Treatment Effects Nicholas C. Henderson Thomas A. Louis Gary Rosner Ravi Varadhan Johns Hopkins University September 28,
More informationA Bayesian Machine Learning Approach for Optimizing Dynamic Treatment Regimes
A Bayesian Machine Learning Approach for Optimizing Dynamic Treatment Regimes Thomas A. Murray, (tamurray@mdanderson.org), Ying Yuan, (yyuan@mdanderson.org), and Peter F. Thall (rex@mdanderson.org) Department
More informationSimple techniques for comparing survival functions with interval-censored data
Simple techniques for comparing survival functions with interval-censored data Jinheum Kim, joint with Chung Mo Nam jinhkim@suwon.ac.kr Department of Applied Statistics University of Suwon Comparing survival
More informationOptimal rules for timing intercourse to achieve pregnancy
Optimal rules for timing intercourse to achieve pregnancy Bruno Scarpa and David Dunson Dipartimento di Statistica ed Economia Applicate Università di Pavia Biostatistics Branch, National Institute of
More informationA Bayesian Nonparametric Approach to Causal Inference for Semi-competing risks
A Bayesian Nonparametric Approach to Causal Inference for Semi-competing risks Y. Xu, D. Scharfstein, P. Mueller, M. Daniels Johns Hopkins, Johns Hopkins, UT-Austin, UF JSM 2018, Vancouver 1 What are semi-competing
More informationPersonalized Treatment Selection Based on Randomized Clinical Trials. Tianxi Cai Department of Biostatistics Harvard School of Public Health
Personalized Treatment Selection Based on Randomized Clinical Trials Tianxi Cai Department of Biostatistics Harvard School of Public Health Outline Motivation A systematic approach to separating subpopulations
More informationChapter 2. Data Analysis
Chapter 2 Data Analysis 2.1. Density Estimation and Survival Analysis The most straightforward application of BNP priors for statistical inference is in density estimation problems. Consider the generic
More informationBiost 518 Applied Biostatistics II. Purpose of Statistics. First Stage of Scientific Investigation. Further Stages of Scientific Investigation
Biost 58 Applied Biostatistics II Scott S. Emerson, M.D., Ph.D. Professor of Biostatistics University of Washington Lecture 5: Review Purpose of Statistics Statistics is about science (Science in the broadest
More informationOptimising Group Sequential Designs. Decision Theory, Dynamic Programming. and Optimal Stopping
: Decision Theory, Dynamic Programming and Optimal Stopping Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj InSPiRe Conference on Methodology
More informationCase Study in the Use of Bayesian Hierarchical Modeling and Simulation for Design and Analysis of a Clinical Trial
Case Study in the Use of Bayesian Hierarchical Modeling and Simulation for Design and Analysis of a Clinical Trial William R. Gillespie Pharsight Corporation Cary, North Carolina, USA PAGE 2003 Verona,
More informationRonald Christensen. University of New Mexico. Albuquerque, New Mexico. Wesley Johnson. University of California, Irvine. Irvine, California
Texts in Statistical Science Bayesian Ideas and Data Analysis An Introduction for Scientists and Statisticians Ronald Christensen University of New Mexico Albuquerque, New Mexico Wesley Johnson University
More informationGroup Sequential Designs: Theory, Computation and Optimisation
Group Sequential Designs: Theory, Computation and Optimisation Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj 8th International Conference
More informationRobustifying Trial-Derived Treatment Rules to a Target Population
1/ 39 Robustifying Trial-Derived Treatment Rules to a Target Population Yingqi Zhao Public Health Sciences Division Fred Hutchinson Cancer Research Center Workshop on Perspectives and Analysis for Personalized
More informationClassification. Classification is similar to regression in that the goal is to use covariates to predict on outcome.
Classification Classification is similar to regression in that the goal is to use covariates to predict on outcome. We still have a vector of covariates X. However, the response is binary (or a few classes),
More informationNon-Parametric Bayes
Non-Parametric Bayes Mark Schmidt UBC Machine Learning Reading Group January 2016 Current Hot Topics in Machine Learning Bayesian learning includes: Gaussian processes. Approximate inference. Bayesian
More informationUse of frequentist and Bayesian approaches for extrapolating from adult efficacy data to design and interpret confirmatory trials in children
Use of frequentist and Bayesian approaches for extrapolating from adult efficacy data to design and interpret confirmatory trials in children Lisa Hampson, Franz Koenig and Martin Posch Department of Mathematics
More informationLongitudinal breast density as a marker of breast cancer risk
Longitudinal breast density as a marker of breast cancer risk C. Armero (1), M. Rué (2), A. Forte (1), C. Forné (2), H. Perpiñán (1), M. Baré (3), and G. Gómez (4) (1) BIOstatnet and Universitat de València,
More informationUniformly Most Powerful Bayesian Tests and Standards for Statistical Evidence
Uniformly Most Powerful Bayesian Tests and Standards for Statistical Evidence Valen E. Johnson Texas A&M University February 27, 2014 Valen E. Johnson Texas A&M University Uniformly most powerful Bayes
More informationAuxiliary-variable-enriched Biomarker Stratified Design
Auxiliary-variable-enriched Biomarker Stratified Design Ting Wang University of North Carolina at Chapel Hill tingwang@live.unc.edu 8th May, 2017 A joint work with Xiaofei Wang, Haibo Zhou, Jianwen Cai
More informationHOW TO DETERMINE THE NUMBER OF SUBJECTS NEEDED FOR MY STUDY?
HOW TO DETERMINE THE NUMBER OF SUBJECTS NEEDED FOR MY STUDY? TUTORIAL ON SAMPLE SIZE AND POWER CALCULATIONS FOR INEQUALITY TESTS. John Zavrakidis j.zavrakidis@nki.nl May 28, 2018 J.Zavrakidis Sample and
More informationLecture 3: Basic Statistical Tools. Bruce Walsh lecture notes Tucson Winter Institute 7-9 Jan 2013
Lecture 3: Basic Statistical Tools Bruce Walsh lecture notes Tucson Winter Institute 7-9 Jan 2013 1 Basic probability Events are possible outcomes from some random process e.g., a genotype is AA, a phenotype
More informationGroup Sequential Tests for Delayed Responses. Christopher Jennison. Lisa Hampson. Workshop on Special Topics on Sequential Methodology
Group Sequential Tests for Delayed Responses Christopher Jennison Department of Mathematical Sciences, University of Bath, UK http://people.bath.ac.uk/mascj Lisa Hampson Department of Mathematics and Statistics,
More information2 Describing Contingency Tables
2 Describing Contingency Tables I. Probability structure of a 2-way contingency table I.1 Contingency Tables X, Y : cat. var. Y usually random (except in a case-control study), response; X can be random
More information6 Sample Size Calculations
6 Sample Size Calculations A major responsibility of a statistician: sample size calculation. Hypothesis Testing: compare treatment 1 (new treatment) to treatment 2 (standard treatment); Assume continuous
More informationPubh 8482: Sequential Analysis
Pubh 8482: Sequential Analysis Joseph S. Koopmeiners Division of Biostatistics University of Minnesota Week 10 Class Summary Last time... We began our discussion of adaptive clinical trials Specifically,
More informationBayesian Updating: Discrete Priors: Spring
Bayesian Updating: Discrete Priors: 18.05 Spring 2017 http://xkcd.com/1236/ Learning from experience Which treatment would you choose? 1. Treatment 1: cured 100% of patients in a trial. 2. Treatment 2:
More informationLecture 1: Bayesian Framework Basics
Lecture 1: Bayesian Framework Basics Melih Kandemir melih.kandemir@iwr.uni-heidelberg.de April 21, 2014 What is this course about? Building Bayesian machine learning models Performing the inference of
More informationAlgorithmisches Lernen/Machine Learning
Algorithmisches Lernen/Machine Learning Part 1: Stefan Wermter Introduction Connectionist Learning (e.g. Neural Networks) Decision-Trees, Genetic Algorithms Part 2: Norman Hendrich Support-Vector Machines
More informationPointwise Exact Bootstrap Distributions of Cost Curves
Pointwise Exact Bootstrap Distributions of Cost Curves Charles Dugas and David Gadoury University of Montréal 25th ICML Helsinki July 2008 Dugas, Gadoury (U Montréal) Cost curves July 8, 2008 1 / 24 Outline
More informationTwo-stage Adaptive Randomization for Delayed Response in Clinical Trials
Two-stage Adaptive Randomization for Delayed Response in Clinical Trials Guosheng Yin Department of Statistics and Actuarial Science The University of Hong Kong Joint work with J. Xu PSI and RSS Journal
More informationPrevious lecture. P-value based combination. Fixed vs random effects models. Meta vs. pooled- analysis. New random effects testing.
Previous lecture P-value based combination. Fixed vs random effects models. Meta vs. pooled- analysis. New random effects testing. Interaction Outline: Definition of interaction Additive versus multiplicative
More informationTime Series and Dynamic Models
Time Series and Dynamic Models Section 1 Intro to Bayesian Inference Carlos M. Carvalho The University of Texas at Austin 1 Outline 1 1. Foundations of Bayesian Statistics 2. Bayesian Estimation 3. The
More informationBayesian Inference and MCMC
Bayesian Inference and MCMC Aryan Arbabi Partly based on MCMC slides from CSC412 Fall 2018 1 / 18 Bayesian Inference - Motivation Consider we have a data set D = {x 1,..., x n }. E.g each x i can be the
More informationReview of probability
Review of probability Computer Sciences 760 Spring 2014 http://pages.cs.wisc.edu/~dpage/cs760/ Goals for the lecture you should understand the following concepts definition of probability random variables
More informationPerformance Evaluation
Performance Evaluation Confusion Matrix: Detected Positive Negative Actual Positive A: True Positive B: False Negative Negative C: False Positive D: True Negative Recall or Sensitivity or True Positive
More informationA Decision-Theoretic Comparison of Treatments to Resolve Air Leaks After Lung Surgery Based on Nonparametric Modeling. Abstract
A Decision-Theoretic Comparison of Treatments to Resolve Air Leaks After Lung Surgery Based on Nonparametric Modeling Yanxun Xu 1 2, Peter F. Thall 3, Peter Müller 4, and Reza J. Mehran 5 Abstract We propose
More informationDetection of Uniform and Non-Uniform Differential Item Functioning by Item Focussed Trees
arxiv:1511.07178v1 [stat.me] 23 Nov 2015 Detection of Uniform and Non-Uniform Differential Functioning by Focussed Trees Moritz Berger & Gerhard Tutz Ludwig-Maximilians-Universität München Akademiestraße
More informationBANA 7046 Data Mining I Lecture 4. Logistic Regression and Classications 1
BANA 7046 Data Mining I Lecture 4. Logistic Regression and Classications 1 Shaobo Li University of Cincinnati 1 Partially based on Hastie, et al. (2009) ESL, and James, et al. (2013) ISLR Data Mining I
More informationLinear Discriminant Analysis Based in part on slides from textbook, slides of Susan Holmes. November 9, Statistics 202: Data Mining
Linear Discriminant Analysis Based in part on slides from textbook, slides of Susan Holmes November 9, 2012 1 / 1 Nearest centroid rule Suppose we break down our data matrix as by the labels yielding (X
More informationComputational Complexity of Bayesian Networks
Computational Complexity of Bayesian Networks UAI, 2015 Complexity theory Many computations on Bayesian networks are NP-hard Meaning (no more, no less) that we cannot hope for poly time algorithms that
More informationNonparametric Bayesian Methods - Lecture I
Nonparametric Bayesian Methods - Lecture I Harry van Zanten Korteweg-de Vries Institute for Mathematics CRiSM Masterclass, April 4-6, 2016 Overview of the lectures I Intro to nonparametric Bayesian statistics
More informationCollinearity/Confounding in richly-parameterized models
Collinearity/Confounding in richly-parameterized models For MLM, it often makes sense to consider X + Zu to be the mean structure, especially for new-style random e ects. This is like an ordinary linear
More informationDefault Priors and Effcient Posterior Computation in Bayesian
Default Priors and Effcient Posterior Computation in Bayesian Factor Analysis January 16, 2010 Presented by Eric Wang, Duke University Background and Motivation A Brief Review of Parameter Expansion Literature
More informationDistance-Based Probability Distribution for Set Partitions with Applications to Bayesian Nonparametrics
Distance-Based Probability Distribution for Set Partitions with Applications to Bayesian Nonparametrics David B. Dahl August 5, 2008 Abstract Integration of several types of data is a burgeoning field.
More information13. The Cochran-Satterthwaite Approximation for Linear Combinations of Mean Squares
13. The Cochran-Satterthwaite Approximation for Linear Combinations of Mean Squares opyright c 2018 Dan Nettleton (Iowa State University) 13. Statistics 510 1 / 18 Suppose M 1,..., M k are independent
More informationGeneralized logit models for nominal multinomial responses. Local odds ratios
Generalized logit models for nominal multinomial responses Categorical Data Analysis, Summer 2015 1/17 Local odds ratios Y 1 2 3 4 1 π 11 π 12 π 13 π 14 π 1+ X 2 π 21 π 22 π 23 π 24 π 2+ 3 π 31 π 32 π
More informationEstimation of Optimal Treatment Regimes Via Machine Learning. Marie Davidian
Estimation of Optimal Treatment Regimes Via Machine Learning Marie Davidian Department of Statistics North Carolina State University Triangle Machine Learning Day April 3, 2018 1/28 Optimal DTRs Via ML
More informationA.I. in health informatics lecture 2 clinical reasoning & probabilistic inference, I. kevin small & byron wallace
A.I. in health informatics lecture 2 clinical reasoning & probabilistic inference, I kevin small & byron wallace today a review of probability random variables, maximum likelihood, etc. crucial for clinical
More informationUniversity of Texas, MD Anderson Cancer Center
University of Texas, MD Anderson Cancer Center UT MD Anderson Cancer Center Department of Biostatistics Working Paper Series Year 2012 Paper 74 Uniformly Most Powerful Bayesian Tests Valen E. Johnson Dept.
More informationEXAM IN STATISTICAL MACHINE LEARNING STATISTISK MASKININLÄRNING
EXAM IN STATISTICAL MACHINE LEARNING STATISTISK MASKININLÄRNING DATE AND TIME: June 9, 2018, 09.00 14.00 RESPONSIBLE TEACHER: Andreas Svensson NUMBER OF PROBLEMS: 5 AIDING MATERIAL: Calculator, mathematical
More informationLecture 8: Information Theory and Statistics
Lecture 8: Information Theory and Statistics Part II: Hypothesis Testing and I-Hsiang Wang Department of Electrical Engineering National Taiwan University ihwang@ntu.edu.tw December 23, 2015 1 / 50 I-Hsiang
More informationAnalysing Survival Endpoints in Randomized Clinical Trials using Generalized Pairwise Comparisons
Analysing Survival Endpoints in Randomized Clinical Trials using Generalized Pairwise Comparisons Dr Julien PERON October 2016 Department of Biostatistics HCL LBBE UCBL Department of Medical oncology HCL
More informationAdvanced Machine Learning
Advanced Machine Learning Nonparametric Bayesian Models --Learning/Reasoning in Open Possible Worlds Eric Xing Lecture 7, August 4, 2009 Reading: Eric Xing Eric Xing @ CMU, 2006-2009 Clustering Eric Xing
More informationEstimating Causal Effects of Organ Transplantation Treatment Regimes
Estimating Causal Effects of Organ Transplantation Treatment Regimes David M. Vock, Jeffrey A. Verdoliva Boatman Division of Biostatistics University of Minnesota July 31, 2018 1 / 27 Hot off the Press
More informationDiscussion of Missing Data Methods in Longitudinal Studies: A Review by Ibrahim and Molenberghs
Discussion of Missing Data Methods in Longitudinal Studies: A Review by Ibrahim and Molenberghs Michael J. Daniels and Chenguang Wang Jan. 18, 2009 First, we would like to thank Joe and Geert for a carefully
More informationData Mining: Concepts and Techniques. (3 rd ed.) Chapter 8. Chapter 8. Classification: Basic Concepts
Data Mining: Concepts and Techniques (3 rd ed.) Chapter 8 Chapter 8. Classification: Basic Concepts Classification: Basic Concepts Decision Tree Induction Bayes Classification Methods Rule-Based Classification
More informationNeutral Bayesian reference models for incidence rates of (rare) clinical events
Neutral Bayesian reference models for incidence rates of (rare) clinical events Jouni Kerman Statistical Methodology, Novartis Pharma AG, Basel BAYES2012, May 10, Aachen Outline Motivation why reference
More informationBMA-Mod : A Bayesian Model Averaging Strategy for Determining Dose-Response Relationships in the Presence of Model Uncertainty
BMA-Mod : A Bayesian Model Averaging Strategy for Determining -Response Relationships in the Presence of Model Uncertainty A. Lawrence Gould KOL 20 October, 2017 Overview and Motivation -Response Trials
More informationMeasures of Association and Variance Estimation
Measures of Association and Variance Estimation Dipankar Bandyopadhyay, Ph.D. Department of Biostatistics, Virginia Commonwealth University D. Bandyopadhyay (VCU) BIOS 625: Categorical Data & GLM 1 / 35
More informationBinomial Model. Lecture 10: Introduction to Logistic Regression. Logistic Regression. Binomial Distribution. n independent trials
Lecture : Introduction to Logistic Regression Ani Manichaikul amanicha@jhsph.edu 2 May 27 Binomial Model n independent trials (e.g., coin tosses) p = probability of success on each trial (e.g., p =! =
More informationPubH 7470: STATISTICS FOR TRANSLATIONAL & CLINICAL RESEARCH
PubH 7470: STATISTICS FOR TRANSLATIONAL & CLINICAL RESEARCH The First Step: SAMPLE SIZE DETERMINATION THE ULTIMATE GOAL The most important, ultimate step of any of clinical research is to do draw inferences;
More informationBayesian Inference of Multiple Gaussian Graphical Models
Bayesian Inference of Multiple Gaussian Graphical Models Christine Peterson,, Francesco Stingo, and Marina Vannucci February 18, 2014 Abstract In this paper, we propose a Bayesian approach to inference
More informationGrundlagen der Künstlichen Intelligenz
Grundlagen der Künstlichen Intelligenz Uncertainty & Probabilities & Bandits Daniel Hennes 16.11.2017 (WS 2017/18) University Stuttgart - IPVS - Machine Learning & Robotics 1 Today Uncertainty Probability
More informationBios 6649: Clinical Trials - Statistical Design and Monitoring
Bios 6649: Clinical Trials - Statistical Design and Monitoring Spring Semester 2015 John M. Kittelson Department of Biostatistics & nformatics Colorado School of Public Health University of Colorado Denver
More informationLecture 10: Introduction to Logistic Regression
Lecture 10: Introduction to Logistic Regression Ani Manichaikul amanicha@jhsph.edu 2 May 2007 Logistic Regression Regression for a response variable that follows a binomial distribution Recall the binomial
More informationDivision of Pharmacoepidemiology And Pharmacoeconomics Technical Report Series
Division of Pharmacoepidemiology And Pharmacoeconomics Technical Report Series Year: 2013 #006 The Expected Value of Information in Prospective Drug Safety Monitoring Jessica M. Franklin a, Amanda R. Patrick
More informationBayesian decision procedures for dose escalation - a re-analysis
Bayesian decision procedures for dose escalation - a re-analysis Maria R Thomas Queen Mary,University of London February 9 th, 2010 Overview Phase I Dose Escalation Trial Terminology Regression Models
More informationREGRESSION ANALYSIS FOR TIME-TO-EVENT DATA THE PROPORTIONAL HAZARDS (COX) MODEL ST520
REGRESSION ANALYSIS FOR TIME-TO-EVENT DATA THE PROPORTIONAL HAZARDS (COX) MODEL ST520 Department of Statistics North Carolina State University Presented by: Butch Tsiatis, Department of Statistics, NCSU
More informationUnobservable Parameter. Observed Random Sample. Calculate Posterior. Choosing Prior. Conjugate prior. population proportion, p prior:
Pi Priors Unobservable Parameter population proportion, p prior: π ( p) Conjugate prior π ( p) ~ Beta( a, b) same PDF family exponential family only Posterior π ( p y) ~ Beta( a + y, b + n y) Observed
More informationFundamentals to Biostatistics. Prof. Chandan Chakraborty Associate Professor School of Medical Science & Technology IIT Kharagpur
Fundamentals to Biostatistics Prof. Chandan Chakraborty Associate Professor School of Medical Science & Technology IIT Kharagpur Statistics collection, analysis, interpretation of data development of new
More informationA Bayesian Nonparametric Model for Predicting Disease Status Using Longitudinal Profiles
A Bayesian Nonparametric Model for Predicting Disease Status Using Longitudinal Profiles Jeremy Gaskins Department of Bioinformatics & Biostatistics University of Louisville Joint work with Claudio Fuentes
More informationA Sampling of IMPACT Research:
A Sampling of IMPACT Research: Methods for Analysis with Dropout and Identifying Optimal Treatment Regimes Marie Davidian Department of Statistics North Carolina State University http://www.stat.ncsu.edu/
More informationProbability and Information Theory. Sargur N. Srihari
Probability and Information Theory Sargur N. srihari@cedar.buffalo.edu 1 Topics in Probability and Information Theory Overview 1. Why Probability? 2. Random Variables 3. Probability Distributions 4. Marginal
More informationECE313 Summer Problem Set 7. Reading: Cond. Prob., Law of total prob., Hypothesis testinng Quiz Date: Tuesday, July 3
ECE313 Summer 2012 Problem Set 7 Reading: Cond. Prob., Law of total prob., Hypothesis testinng Quiz Date: Tuesday, July 3 Note: It is very important that you solve the problems first and check the solutions
More informationReconstruction of individual patient data for meta analysis via Bayesian approach
Reconstruction of individual patient data for meta analysis via Bayesian approach Yusuke Yamaguchi, Wataru Sakamoto and Shingo Shirahata Graduate School of Engineering Science, Osaka University Masashi
More informationModelling geoadditive survival data
Modelling geoadditive survival data Thomas Kneib & Ludwig Fahrmeir Department of Statistics, Ludwig-Maximilians-University Munich 1. Leukemia survival data 2. Structured hazard regression 3. Mixed model
More informationMonitoring clinical trial outcomes with delayed response: incorporating pipeline data in group sequential designs. Christopher Jennison
Monitoring clinical trial outcomes with delayed response: incorporating pipeline data in group sequential designs Christopher Jennison Department of Mathematical Sciences, University of Bath http://people.bath.ac.uk/mascj
More informationBayesian Optimal Interval Design for Phase I Clinical Trials
Bayesian Optimal Interval Design for Phase I Clinical Trials Department of Biostatistics The University of Texas, MD Anderson Cancer Center Joint work with Suyu Liu Phase I oncology trials The goal of
More informationLecture 2: Poisson and logistic regression
Dankmar Böhning Southampton Statistical Sciences Research Institute University of Southampton, UK S 3 RI, 11-12 December 2014 introduction to Poisson regression application to the BELCAP study introduction
More informationDIFFERENT APPROACHES TO STATISTICAL INFERENCE: HYPOTHESIS TESTING VERSUS BAYESIAN ANALYSIS
DIFFERENT APPROACHES TO STATISTICAL INFERENCE: HYPOTHESIS TESTING VERSUS BAYESIAN ANALYSIS THUY ANH NGO 1. Introduction Statistics are easily come across in our daily life. Statements such as the average
More informationHybrid Dirichlet processes for functional data
Hybrid Dirichlet processes for functional data Sonia Petrone Università Bocconi, Milano Joint work with Michele Guindani - U.T. MD Anderson Cancer Center, Houston and Alan Gelfand - Duke University, USA
More informationChapter 2. Binary and M-ary Hypothesis Testing 2.1 Introduction (Levy 2.1)
Chapter 2. Binary and M-ary Hypothesis Testing 2.1 Introduction (Levy 2.1) Detection problems can usually be casted as binary or M-ary hypothesis testing problems. Applications: This chapter: Simple hypothesis
More informationBase Rates and Bayes Theorem
Slides to accompany Grove s handout March 8, 2016 Table of contents 1 Diagnostic and Prognostic Inference 2 Example inferences Does this patient have Alzheimer s disease, schizophrenia, depression, etc.?
More informationLecture 3 Classification, Logistic Regression
Lecture 3 Classification, Logistic Regression Fredrik Lindsten Division of Systems and Control Department of Information Technology Uppsala University. Email: fredrik.lindsten@it.uu.se F. Lindsten Summary
More informationBayesian nonparametric estimation of finite population quantities in absence of design information on nonsampled units
Bayesian nonparametric estimation of finite population quantities in absence of design information on nonsampled units Sahar Z Zangeneh Robert W. Keener Roderick J.A. Little Abstract In Probability proportional
More informationA new strategy for meta-analysis of continuous covariates in observational studies with IPD. Willi Sauerbrei & Patrick Royston
A new strategy for meta-analysis of continuous covariates in observational studies with IPD Willi Sauerbrei & Patrick Royston Overview Motivation Continuous variables functional form Fractional polynomials
More informationNaïve Bayesian. From Han Kamber Pei
Naïve Bayesian From Han Kamber Pei Bayesian Theorem: Basics Let X be a data sample ( evidence ): class label is unknown Let H be a hypothesis that X belongs to class C Classification is to determine H
More informationThree-group ROC predictive analysis for ordinal outcomes
Three-group ROC predictive analysis for ordinal outcomes Tahani Coolen-Maturi Durham University Business School Durham University, UK tahani.maturi@durham.ac.uk June 26, 2016 Abstract Measuring the accuracy
More informationFrequentist Accuracy of Bayesian Estimates
Frequentist Accuracy of Bayesian Estimates Bradley Efron Stanford University RSS Journal Webinar Objective Bayesian Inference Probability family F = {f µ (x), µ Ω} Parameter of interest: θ = t(µ) Prior
More informationSupplementary Tables and Figures
Supplementary Tables Supplementary Tables and Figures Supplementary Table 1: Tumor types and samples analyzed. Supplementary Table 2: Genes analyzed here. Supplementary Table 3: Statistically significant
More informationA Decision Theoretic Approach to Causality
A Decision Theoretic Approach to Causality Vanessa Didelez School of Mathematics University of Bristol (based on joint work with Philip Dawid) Bordeaux, June 2011 Based on: Dawid & Didelez (2010). Identifying
More informationMultivariable Fractional Polynomials
Multivariable Fractional Polynomials Axel Benner September 7, 2015 Contents 1 Introduction 1 2 Inventory of functions 1 3 Usage in R 2 3.1 Model selection........................................ 3 4 Example
More information